<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210714051889N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-03-11</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Smartphone-Based Educational Program on Self-Efficacy of Patients Undergoing Heart Valve Surgery and the Family Caregivers' Burden</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Smartphone-Based Educational Program on Self-Efficacy of Patients Undergoing Heart Valve Surgery and the Family Caregivers' Burden: Parallel Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-30</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68216</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Randomization will be done by block method. First, the random allocation sequence and block list will be obtained by the statistical consultant. The website https://www.sealedenvelope.com is used to generate a random sequence for block-type randomization so that there is no limit on the number of blocks for random allocation. In this research, the block method with a volume of 4 is used to create a random allocation sequence. According to the total number of samples required for the study, which was 60 family members and patients (30 patients and family members in the test group (A) and 30 family members and patients in the control group (B)), in 15 quadruple blocks including Two groups A and B will be randomly selected through the site.
  Based on the list of randomized blocks of four prepared, a trained nursing expert outside the research group is responsible for registering participants and assigning patients randomly, after the entry of each patient, according to the 15 blocks of four prepared in the first stage, each patient is Randomly placed in group A (intervention) or B (control group). For example, after randomly selecting the BBAB block, the patients were placed in the control, control, intervention and control groups in the order of their entry. And the sampling process is done consecutively in the same way until the sampling is completed, and the code of each patient was also assigned to his family member. People are assigned to the desired group in the order of their entry into the study and randomly through randomized blocks.</study_design>
      <phase>N/A</phase>
      <hc_freetext>of Patients Undergoing Heart Valve Surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention is in the form of providing an application (Android application) that can be installed on the phone, which provides information about heart valve failure and dysfunction, familiarity with drugs and the necessity of using them, the importance of the role of self-efficacy in the patient, and the beneficial effects of self-care and emphasis. on the importance of the role of caregivers and reducing the burden of care and how to take proper care of oneself and its dimensions and the importance of how to manage symptoms and signs in emergency situations and the importance of making changes in lifestyle for the patient and caregiver (including following a proper diet, mobility and exercise, It includes medication adherence, smoking cessation, weight control) and other educational information. The smartphone-based application is installed by the researcher for the patient and caregiver in the intervention group, and a session is taught on how to use the application (in order to prevent access to the application by the control group during the intervention, a special password is required to enter the program given to a phone). At the same time, the intervention group will use the routine training programs of the heart clinic. During the implementation of the intervention until the re-completion of the questionnaires, the researcher was in contact with the caregivers and the patient through telephone calls and questions and answers with the participants through the formation of a group in the available social network (if the participants are satisfied). And while following up by phone, their questions will be answered. After 8 weeks from the end of the intervention, the questionnaires will be given to the intervention group again. Intervention 2: Control group: At the same time, the control group will benefit from the clinic's routine training in the form of face-to-face training and hospital pamphlets. The relevant questionnaires are designed face-to-face or press-line and are completed by the research sample (including the patient and his caregiver) and face-to-face training sessions are arranged in one to two sessions according to the needs of the individual and then to answer questions no. The phone will be provided to them.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The significance level of the study is not yet known, and it will be concluded after a complete study.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>MOHAMMAD ZAREI</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 12, Unit 1, 2 Moghadam Alley, Shahid Ali Mazaheri Alley, South Rodaki St., Tehran</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1346756168</zip>
        <telephone>+98 21 2624 4174</telephone>
        <email>zarei .mohammad72@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Neda Sanaie</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran, Wali Asr St., Niayesh Intersection, in front of Shahid Rajaei Heart Hospital, Faculty of Nursing and Midwifery</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 8865 5366</telephone>
        <email>nedasanaie@ymail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The age range of people should be between 18 and 65 years.
Have an Android smartphone.
Patients undergo mechanical valve surgery for the first time.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Suffering from known physical and mental diseases that affect the quality of life, such as dialysis, or other known mental problems, such as depression and schizophrenia, which require special medication or diet (according to the patient's self-report).
People who have participated in another educational program during the research.
People who have hearing, visual and touch disorders or who are not able to speak Persian language.
People who underwent valve repair or biological valve.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention is in the form of providing an application (Android application) that can be installed on the phone, which provides information about heart valve failure and dysfunction, familiarity with drugs and the necessity of using them, the importance of the role of self-efficacy in the patient, and the beneficial effects of self-care and emphasis. on the importance of the role of caregivers and reducing the burden of care and how to take proper care of oneself and its dimensions and the importance of how to manage symptoms and signs in emergency situations and the importance of making changes in lifestyle for the patient and caregiver (including following a proper diet, mobility and exercise, It includes medication adherence, smoking cessation, weight control) and other educational information. The smartphone-based application is installed by the researcher for the patient and caregiver in the intervention group, and a session is taught on how to use the application (in order to prevent access to the application by the control group during the intervention, a special password is required to enter the program given to a phone). At the same time, the intervention group will use the routine training programs of the heart clinic. During the implementation of the intervention until the re-completion of the questionnaires, the researcher was in contact with the caregivers and the patient through telephone calls and questions and answers with the participants through the formation of a group in the available social network (if the participants are satisfied). And while following up by phone, their questions will be answered. After 8 weeks from the end of the intervention, the questionnaires will be given to the intervention group again.</i_keyword>
      <i_keyword>Control group: At the same time, the control group will benefit from the clinic's routine training in the form of face-to-face training and hospital pamphlets. The relevant questionnaires are designed face-to-face or press-line and are completed by the research sample (including the patient and his caregiver) and face-to-face training sessions are arranged in one to two sessions according to the needs of the individual and then to answer questions no. The phone will be provided to them.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Self-efficacy of patients undergoing heart valve surgery. Timepoint: Before the intervention and eight weeks after the intervention. Method of measurement: Patient's demographic information questionnaire and Sullivan Cardiac Self-Efficacy Questionnaire (SCSES) are completed by the patient. Sullivan's self-efficacy questionnaire has 16 questions, which evaluates the level of confidence and self-efficacy of patients in the field of compliance with general care, control of disease symptoms, and compliance with medication orders. The questionnaire is scored on a 5-point Likert scale, including completely = 4, very much = 3, almost = 2, a little = 1 to not at all = 0.</prim_outcome>
      <prim_outcome>Caring burden of family caregivers. Timepoint: Before the intervention and eight weeks after the intervention. Method of measurement: The caregiver demographic information questionnaire and the CBI care burden questionnaire are completed by the caregiver. The care burden questionnaire has 24 statements, which was created in 1989 by Novak and Guest to measure the objective and mental burden of care and measures the burden of mental care with more emphasis. This questionnaire has five subscales and includes time-dependent caregiving burden, evolutionary caregiving burden, physical caregiving burden, social caregiving burden, and emotional caregiving burden. ), it measures partially correct (score 2), correct (score 3) and completely correct (score 4), therefore, the scores obtained from this questionnaire are from zero to 96.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-10-31</approval_date>
        <contact_name>Ethics committee in research of the Faculties of Pharmacy, Nursing and Midwifery, Shahid Beheshti Un</contact_name>
        <contact_address>Resalat Highway, Kerman Street, Shahid Mousavi Street tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
